Cryoablation for Rib Fracture Pain Control
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find better ways to control long-term pain for older adults with rib fractures. Researchers will compare a new treatment called cryoneurolysis, which uses cold to numb nerves, against the standard care usually provided after such injuries. They aim to determine if this new method can help patients recover more quickly and with fewer complications. Individuals aged 65 or older, with a rib fracture causing significant pain, and admitted to the Stanford Emergency Department after an injury, might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative pain management research.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that cryoneurolysis is safe for rib fracture pain control?
Research has shown that percutaneous cryoneurolysis, a method that freezes nerves to block pain, is quite safe. Studies have found it effective for managing pain from broken ribs, especially in older adults. This treatment successfully reduces the need for strong painkillers, aiding recovery. Reports of serious side effects are rare, making it a well-tolerated option for pain relief.12345
Why are researchers excited about this trial?
Researchers are excited about cryoablation for rib fracture pain control because it offers a novel way to manage pain. Unlike traditional options like pain medications or nerve blocks, cryoablation uses extreme cold to target and temporarily disable the nerves responsible for pain, potentially providing longer-lasting relief. This method is minimally invasive and can be precisely guided with imaging, which may reduce the risk of complications and improve recovery times. For patients 65 and older, this approach could mean better pain management with fewer side effects from medications.
What evidence suggests that cryoneurolysis could be effective for rib fracture pain control?
In this trial, participants will be randomized to receive either cryoneurolysis or standard-of-care treatment for rib fracture pain. Research has shown that cryoneurolysis is a promising method for treating pain from broken ribs. Studies have found that this approach can significantly reduce pain and lessen the need for opioid painkillers. It uses cold temperatures to temporarily block pain signals from the nerves around the ribs. This treatment has improved life after injury by providing effective pain relief. Additionally, cryoneurolysis is considered safe and effective when used alongside standard pain management for individuals with rib fractures.12367
Who Is on the Research Team?
Joseph D Forrester, MD
Principal Investigator
Stanford University
Nishita Kothary, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for elderly patients over 65 with acute rib fractures who experience significant pain (score of 5 or higher) when taking deep breaths. They must be admitted to Stanford Emergency Department and have no metastasis to ribs, severe coagulation issues, very low GCS scores, or specific rib fracture locations that make them unsuitable for the treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive percutaneous image-guided cryoneurolysis (pICN) or standard-of-care treatment within 72 hours of presentation
Follow-up
Participants are monitored for pain control and functional outcomes after discharge
What Are the Treatments Tested in This Trial?
Interventions
- Cryoneurolysis
- Standard of Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor